Cardinal Health Nitrile Blue Examination Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate
FDA 510(k) K261749 · Cardinalhealth
510(k) numberK261749
Submission
- Device name
- Cardinal Health Nitrile Blue Examination Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate
- Applicant
- Cardinalhealth
Waukegan, IL, US - Received
- May 28, 2026
- Decision date
- September 2, 2026
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) statement available from FDA
Device classification
No product code recorded.
More from Cardinalhealth
| 510(k) | Device | Decision |
|---|---|---|
| K252313 | Cardinal Health Nitrile Examination Gloves Extended CuffLZC · Traditional | 01/14/2026SE |
| K243660 | Monoject 1mL Tuberculin Syringe Luer-Lock Tip (1180100777); Monoject 3mL Syringe…FMF · Traditional | 08/22/2025SE |
| K243652 | Monoject Enteral Syringe with ENFit Connector (401SE); Monoject Enteral Syringe with…PNR · Special | 12/19/2024SE |
| K230569 | Cardinal Health Surgical Mask With Anti-fog Hydrogel (Level 3 ); Cardinal Health…FXX · Abbreviated | 07/03/2023SE |
| K213174 | Salem Sump Silicone Dual Lumen Stomach Tube with ENFit ConnectionPIF · Traditional | 05/19/2022SE |
| K202217 | Kendall NPWT Incision Management DeviceOMP · Traditional | 06/04/2021SE |
| K191101 | Kendall NPWT Incision Management Dressing KitOMP · Traditional | 07/31/2020SE |
| K190923 | Salem Sump Dual Lumen Stomach Tube with ENFit ConnectionPIF · Traditional | 11/07/2019SE |
| K171499 | Occlusion Detection Dressing KitOMP · Traditional | 09/22/2017SE |
| K161418 | Cardinal Health NPWT Irrigation Tubing Set, Cardinal Health NPWT Irrigation Delivery SetOMP · Traditional | 01/19/2017SE |
Questions and answers
When was Cardinal Health Nitrile Blue Examination Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate cleared by the FDA?
Cardinal Health Nitrile Blue Examination Gloves Tested for Use with Chemotherapy Drugs and Fentanyl Citrate (K261749) received a 510(k) decision of Substantially Equivalent on September 2, 2026, 97 days after the submission was received.